Effectiveness of network analysis-driven personalized digital interventions versus standard intervention for...

Area of Science:

• Psychiatry
• Digital Health
• Network Science

Background:

• Network approaches to psychopathology identify core and bridge symptoms as intervention targets.
• Previous studies have been primarily descriptive or retrospective, lacking prospective testing of personalized interventions.
• A gap exists in prospectively evaluating tailored interventions based on person-specific symptom networks.

Purpose of the Study:

• To prospectively investigate if a network-driven, person-specific sequencing of intervention modules offers added benefit over a standardized sequence.
• To conduct a proof-of-concept pilot randomized controlled trial comparing personalized versus standardized digital interventions for depressive symptoms.

Main Methods:

• Recruited participants aged 18-29 with depressive symptoms, screened via Mini International Neuropsychiatric Interview.
• Compared a digital intervention sequenced by network analysis of ecological momentary assessment (EMA) data with a standardized fixed-sequence intervention.
• Assessed depressive symptoms, including self-harm or suicidal thoughts, at post-intervention and 1- and 3-month follow-ups.

Main Results:

• Both personalized and standardized interventions led to significant improvements in depressive symptoms over time (p_fdr < 0.01) with large effect sizes at post-intervention (d=1.24 and d=1.15, respectively).
• Improvements were maintained at 1- and 3-month follow-ups for both groups.
• No statistically significant difference was found between the personalized and standardized intervention groups (p=0.987), indicating small, inconclusive between-arm differences in this pilot study.

Conclusions:

• This pilot study suggests that personalized, network-informed digital interventions may not offer immediate advantages over standardized approaches for depression.
• The non-significant findings highlight the need for further trials to determine specific conditions where personalized approaches may yield benefits.
• Future research should focus on refining network-informed strategies and identifying patient subgroups that could benefit most from personalized sequencing.